長い非コーディングRNASNHG12は,E3リガゼTRIM25を標的にすることでKEAP1の安定性とフェロプトーシス感受性を定義する
Yubo Guo1, Shuang Zhu2, Wenjie Wu3
1State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China; Hubei Hongshan Laboratory, Wuhan, Hubei, 430070, China.
The Journal of biological chemistry
|September 6, 2025
まとめ
この研究では,SNHG12が癌治療に不可欠な細胞死の一種であるフェロプトーシスの新しい調節剤であると特定しました. SNHG12のアップレギュレーションは,TRIM25との相互作用によってフェロプトーシスを促進し,新しい治療目標を提供します.
科学分野:
- 分子生物学
- 細胞死 研究
- ガン治療薬
背景:
- フェロプトーシスという 鉄に依存したプログラム細胞死は 癌治療の有望な手段です
- SNHGのような長い非コーディングRNA (lncRNA) は,がんの進行と薬剤耐性における役割としてますます認識されています.
研究 の 目的:
- フェロプトーシスの調節における SNHG12の役割を調査する.
- SNHG12がフェロプトーシスを調節する分子機構を解明する.
- 癌におけるSNHG12媒介経路を標的とした治療の可能性を調査する.
主な方法:
- SNHG12発現を評価するための定量的リアルタイムPCR
- フェロプトーシスを測定するための細胞活力アッセイと鉄アッセイ
- 分子相互作用を分析するために RNA 免疫降水とウエスタン・ブラッティング.
- CRISPR-Cas9の遺伝子編集で SNHG12の発現を操作する
主要な成果:
- SNHG12の発現は,フェロプトーシス誘導の間に上昇調節され,潜在的にP53によって調節される.
- SNHG12の静止はフェロプトーシスを抑制し,過剰発現は加速する.
- SNHG12はTRIM25と相互作用し,KEAP1の分解を防止し,その結果,NRF2の抗酸化反応を抑制する.
- このメカニズムは,細胞内不活性鉄とGSHの減少を引き起こし,癌細胞をフェロプトーシスに敏感にします.
結論:
- SNHG12は,がん細胞における新しいフェロプトーシス促進 lncRNAとして作用する.
- SNHG12,TRIM25,KEAP1を含む新しい規制軸はフェロプトーシスを制御する.
- SNHG12- TRIM25- KEAP1経路をターゲットにすることは,フェロプトーシスベースのがん治療の強化のための潜在的な戦略です.
関連する概念動画
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Protein Folding Quality Check in the RER
3.8K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.8K
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K


